Our Pricing

Mounjaro 10mg: UK Clinical Guide and Online Access

When you buy Mounjaro 10mg online UK from Cured Pharmacy, you're accessing genuine tirzepatide pens at £135.00 with full clinical support from our UK-registered prescribers. The 10mg dose represents a mid-maintenance strength in the Mounjaro dosing schedule, typically prescribed after patients have successfully tolerated the 5mg starter dose and require further weight management support.

Understanding Mounjaro 10mg Dosing in UK Clinical Practice

Mounjaro 10mg is the third dose level in the tirzepatide titration schedule approved by the MHRA for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities [1]. UK prescribers typically escalate patients to this strength after four weeks on the 5mg dose, allowing the body to adapt gradually to tirzepatide's dual GIP/GLP-1 receptor agonist mechanism.

The structured dose escalation protocol—starting at 2.5mg, then 5mg, then 10mg—significantly reduces gastrointestinal side effects compared to starting at higher doses [1]. Clinical data from the SURMOUNT-1 trial demonstrated that patients who reached and maintained the 10mg or 15mg doses achieved average weight reductions of 20.9% and 22.5% respectively over 72 weeks [2].

Your UK prescriber will determine whether 10mg is your optimal maintenance dose or whether further titration to 12.5mg or 15mg is clinically appropriate based on your weight loss response, tolerability, and individual health profile. All dose adjustments require clinical review and cannot be self-directed.

How Mounjaro 10mg Works: Dual Receptor Mechanism

Tirzepatide, the active pharmaceutical ingredient in Mounjaro, is the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK [1]. This dual mechanism distinguishes it from single-pathway treatments like semaglutide (Wegovy) or liraglutide (Saxenda).

At the 10mg dose, tirzepatide activates GLP-1 receptors to reduce appetite, slow gastric emptying, and improve glycaemic control, whilst simultaneously engaging GIP receptors to enhance insulin secretion and potentially improve fat metabolism [3]. This synergistic action produces greater weight loss outcomes than GLP-1 receptor agonism alone.

In head-to-head trials, tirzepatide 10mg and 15mg demonstrated superior weight reduction compared to semaglutide 1mg, with patients achieving an additional 5-7 percentage points of body weight loss on average [4]. The 10mg dose provides substantial clinical benefit whilst remaining below the maximum licensed strength, offering room for further titration if needed.

Expected Timeline on Mounjaro 10mg

Most patients reach the 10mg dose approximately 8-12 weeks after starting treatment, following the standard titration schedule of 2.5mg for four weeks, then 5mg for four weeks [1]. Meaningful weight loss typically becomes evident during the 5mg phase, with acceleration once the 10mg dose is established.

UK clinical guidelines recommend assessing treatment response at 16 weeks. If you haven't achieved at least 5% body weight reduction by this point, your prescriber may review whether continued treatment is appropriate or whether dose adjustment is warranted, subject to tolerability and contraindications.

Buy Mounjaro 10mg Online UK: The Cured Pharmacy Process

Purchasing Mounjaro 10mg through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. Our UK-registered prescribers review your medical history, current medications, weight management goals, and any contraindications to tirzepatide therapy.

If clinically appropriate, your prescriber will issue an NHS-valid private prescription, and our UK-licensed pharmacy (GPhC 9012511) dispenses genuine Mounjaro KwikPens sourced directly from licensed UK wholesalers. Every pen is MHRA-approved and carries full product licensing documentation.

We provide transparent upfront pricing at £135.00 for your first order, with costs displayed before you complete the consultation. There are no hidden fees, subscription traps, or surprise charges. Delivery is fully discreet, with plain packaging and no pharmacy branding visible externally.

Prescription Requirements for Mounjaro 10mg

Mounjaro is a prescription-only medicine (POM) in the UK, meaning it cannot be supplied without a valid prescription from a UK-registered prescriber. Our clinical team assesses suitability based on NICE and MHRA guidance, considering your BMI, weight-related health conditions, previous weight loss attempts, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1].

Patients typically need to demonstrate that lifestyle interventions alone have been insufficient before prescription weight loss medications are considered. Our prescribers follow the same clinical standards as NHS GPs, ensuring safe, evidence-based prescribing practices.

Mounjaro 10mg vs Other Weight Loss Treatments

UK patients have several prescription weight loss options, each with distinct mechanisms, dosing schedules, and clinical profiles. Mounjaro's dual receptor agonism offers advantages in efficacy, whilst other treatments may suit different patient needs or budgets.

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [5]. Whilst highly effective, head-to-head studies show tirzepatide produces greater weight reduction at comparable doses. Saxenda (liraglutide) requires daily injections and typically achieves 8-10% weight loss, making it less potent but still clinically meaningful for appropriate patients.

Oral treatments like Orlistat and Mysimba work through entirely different mechanisms—Orlistat blocks fat absorption in the gut, whilst Mysimba combines naltrexone and bupropion to reduce appetite and cravings. These may be considered for patients who prefer non-injectable options or have contraindications to GLP-1 therapies.

Side Effects and Safety Considerations at 10mg

The most common side effects of Mounjaro 10mg are gastrointestinal: nausea (reported in 20-30% of patients), diarrhoea, constipation, vomiting, and abdominal discomfort [1]. These effects are typically mild to moderate and diminish over time as your body adapts to the medication. The gradual dose escalation protocol specifically aims to minimise these symptoms.

Serious but rare adverse events include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal effects), and hypoglycaemia when used with insulin or sulfonylureas [1]. Patients should seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, or signs of allergic reaction.

Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though causality in humans has not been established [1]. It is contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Your prescriber will screen for these conditions during your consultation.

Managing Side Effects on Mounjaro 10mg

If you experience significant nausea or gastrointestinal upset on the 10mg dose, your prescriber may recommend temporarily reducing to 5mg or implementing dietary modifications—eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can all help manage symptoms.

Never adjust your dose without prescriber guidance. If side effects become intolerable or you experience warning signs of serious complications, contact our clinical team immediately or seek NHS urgent care services as appropriate.

Mounjaro 10mg Price UK: Cost and Value Comparison

At Cured Pharmacy, Mounjaro 10mg is priced at £135.00 for your first order, representing competitive UK pricing for genuine, UK-licensed tirzepatide pens. This transparent cost structure allows you to budget for treatment without hidden fees or subscription commitments.

When evaluating cost, consider the clinical value: Mounjaro has demonstrated superior weight loss outcomes compared to other prescription treatments in direct comparative trials [4]. The once-weekly injection schedule also offers convenience compared to daily medications, potentially improving long-term adherence.

Treatment duration varies by individual response and clinical goals. Many patients require 6-12 months of therapy to achieve and consolidate meaningful weight loss, with some continuing longer-term maintenance therapy at lower doses. Your prescriber will review progress regularly and adjust treatment plans based on your response, tolerability, and evolving health needs.

Maximising Value from Your Treatment

Weight loss medications work best when combined with sustainable lifestyle changes—a balanced, calorie-controlled diet and increased physical activity enhance outcomes and help maintain weight loss after treatment concludes [2]. Our clinical team can provide guidance on evidence-based lifestyle interventions to complement your medication.

Regular follow-up with your prescriber ensures you're on the optimal dose, managing side effects effectively, and achieving appropriate treatment response. These reviews are included in your care pathway at Cured Pharmacy, with no additional consultation fees for ongoing prescriptions.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 10 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14553
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro (tirzepatide) is a prescription-only medicine indicated for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, used alongside a reduced-calorie diet and increased physical activity. Individual results vary. Always consult a qualified healthcare professional before starting any new medication or weight loss programme.